Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07763067
Acceptability and Outcomes of an Online Parent-Mediated Intervention for Young Autistic ChildrenHerguner Therapy Private ClinicCompletedNot Applicable
NCT07763067Completed
Not Applicable
Acceptability and Outcomes of an Online Parent-Mediated Intervention for Young A...Herguner Therapy Private...
NCT07763587
Analysis of Multimodal Psychosomatic Comorbidity Burden in Breast Cancer and Benefit Evaluation of Acupuncture Collaborative Management RegimenFirst Teaching Hospital of Tianjin University of Traditional Chinese MedicineNot Yet RecruitingNot Applicable
NCT07763587Not Yet Recruiting
Not Applicable
Analysis of Multimodal Psychosomatic Comorbidity Burden in Breast Cancer and Ben...First Teaching Hospital o...
NCT07762443
A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia AreataJiangsu vcare pharmaceutical technology co., LTDNot Yet RecruitingPhase 1
NCT07762443Not Yet Recruiting
Phase 1
A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Are...Jiangsu vcare pharmaceuti...
NCT07762703
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio CorpNot Yet RecruitingPhase 1
NCT07762703Not Yet Recruiting
Phase 1
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metasta...BreakBio Corp
NCT07764003
A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Response to 2nd-generation H1-AHsHangzhou Highlightll Pharmaceutical Co., LtdNot Yet RecruitingPhase 2
NCT07764003Not Yet Recruiting
Phase 2
A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Re...Hangzhou Highlightll Phar...
NCT07762040
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting Multiple SclerosisAssiut UniversityNot Yet Recruiting
NCT07762040Not Yet Recruiting
—
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting...Assiut University
NCT07763990
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FILLERHallura Ltd.RecruitingNot Applicable
NCT07763990Recruiting
Not Applicable
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FI...Hallura Ltd.
NCT07762976
Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal CarcinomaFudan UniversityRecruitingPhase 2
NCT07762976Recruiting
Phase 2
Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasoph...Fudan University
NCT07763912
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fed Study.ADIUMCompletedNot Applicable
NCT07763912Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07763951
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fast Study.ADIUMCompletedNot Applicable
NCT07763951Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07762027
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus InfectionAssembly BiosciencesNot Yet RecruitingPhase 2
NCT07762027Not Yet Recruiting
Phase 2
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Part...Assembly Biosciences
NCT07763665
Anti-inflammatory Effect of MgSO₄ in Patients With Moderate Traumatic Brain Injury by Measurming Nucleotide-binding Oligomerization Domain-Like Receptor Pyrin Domain-containing 3 (NLRP3) Inflammasome-a Multiprotein ComplexAssiut UniversityNot Yet RecruitingPhase 4
NCT07763665Not Yet Recruiting
Phase 4
Anti-inflammatory Effect of MgSO₄ in Patients With Moderate Traumatic Brain Inju...Assiut University
NCT07763171
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and PD-L1 TAP Score of 5 or More Advanced Gastroesophageal AdenocarcinomaGruppo Oncologico del Nord-OvestNot Yet RecruitingPhase 3
NCT07763171Not Yet Recruiting
Phase 3
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-neg...Gruppo Oncologico del Nor...
NCT07763782
Dose-Response Structured Calf Muscle Pump Activation Strategies Versus Unsupervised Home WalksMTI UniversityNot Yet RecruitingNot Applicable
NCT07763782Not Yet Recruiting
Not Applicable
Dose-Response Structured Calf Muscle Pump Activation Strategies Versus Unsupervi...MTI University
NCT07764172
Sarcopenia in Acute Ischemic StrokeUniversity Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba)Recruiting
NCT07762898
Sedentary Behavior Intervention for Older Adults With Coronary Heart Disease and FrailtyGansu University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07762898Not Yet Recruiting
Not Applicable
Sedentary Behavior Intervention for Older Adults With Coronary Heart Disease and...Gansu University of Chine...
NCT07763301
YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic MalignanciesWest China HospitalRecruitingPhase 1
NCT07763301Recruiting
Phase 1
YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignan...West China Hospital
NCT07762287
Evaluation of Possible Ways the Body May Process Two Different Forms of Elinzanetant in Healthy Study ParticipantsBayerRecruitingPhase 1
NCT07762287Recruiting
Phase 1
Evaluation of Possible Ways the Body May Process Two Different Forms of Elinzane...Bayer
NCT07762196
Measuring the Effects of Music-Listening On Distress After Intensive CareNHS FifeNot Yet RecruitingNot Applicable
NCT07762196Not Yet Recruiting
Not Applicable
Measuring the Effects of Music-Listening On Distress After Intensive CareNHS Fife
Result Breakdown
Not yet recruiting11 (55%)
Recruiting6 (30%)
Completed3 (15%)
not_applicable8 (40%)
Phase 14 (20%)
Phase 23 (15%)
Not Specified3 (15%)
Phase 41 (5%)
Phase 31 (5%)